Optibiotix Health Plc
Company Profile
Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company Summary
Investor Access
08
Aug
Event information
Management will hold the company’s AGM on 8 August 2024
Please check here for more information: https://www.londonstockexchange.com/news-article/OPTI/final-results/16541766
Venue
Offices of Peterhouse Capital Limited, 3rd Floor, 80 Cheapside, London EC2V 6EE.
Time
Thursday 8 August 2024 at 12pm
Financial Calendar
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results | 28 June |
| Interim Results* | September |
| AGM | 8 August |
* Months based on previous announcements of this kind
